Please login to the form below

Not currently logged in
Email:
Password:

ALK-Abello appoints Søren Jelert as CFO

He will be based at the company’s headquarters in Denmark

Soren JelertDansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company.

Jelert most recently served as a general manager for NNE, an engineering company that specialises in supporting pharmaceutical company engineering projects.

He said: “This new role offers me the opportunity to use my knowledge and experience to support and further develop ALK as it works to build a new growth platform and to become a truly global allergy company.”

His career has seen him serve in various capacities for Novo Nordisk, including as finance director Europe North and manager operations, finance.

Carsten Hellmann, president and chief executive officer, ALK, said: “Søren brings a wealth of experience to ALK, in particular from his previous pharmaceutical industry-focused roles at NNE and Novo Nordisk.

“He has a proven track record of financial leadership and he has also played a pivotal role in transformation processes that are comparable to the one we are embarking upon at ALK.”

Jelert will be based at ALK’s headquarters in Hørsholm, Denmark and will report directly to Hellmann.

11th December 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics